Safety, Sourcing, and Why Medical Oversight Is Non-Negotiable BPC-157 has a strong safety record in animal studies notably, the lethal dose (LD1) has not been achieved across decades of preclinical research, and it has been used in human ulcerative colitis and multiple sclerosis trials without reported toxicity.6 But the absence of adverse events in animals does not translate directly to human safety, particularly at unregulated doses from unverified sources
Thats why our peptides are purity-tested, formulated for human use, prescribed by a licensed provider, and delivered with medical oversight
To understand where this fits, see how NAD+ vs Peptides: Differences, Combining and Cost, and how it is approached at Perfect B in Doral
TB-500: Practical Comparison for Patients What Recovery Peptides Cannot Replace Recovery peptides are sometimes discussed as if they can replace the fundamentals